Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Garly R Saint Croix"'
Autor:
Salih N. Grevious, Marcelo F. Fernandes, Ama K. Annor, Michel Ibrahim, Garly R. Saint Croix, Eduardo de Marchena, Mauricio G. Cohen, Carlos E. Alfonso
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 12 (2020)
Background Right ventricular systolic dysfunction (RVSD) is a known risk factor for adverse outcome in surgical aortic valve replacement. Transcatheter aortic valve replacement (TAVR), on the other hand, has been shown to be either beneficial or have
Externí odkaz:
https://doaj.org/article/1ad42e2c4321452ca729b55a47a22968
Publikováno v:
Journal of Interventional Cardiology, Vol 2020 (2020)
Introduction. Transcatheter aortic valve replacement (TAVR) is now the treatment of choice for patients with severe aortic stenosis regardless of their surgical risk. Right bundle branch block (RBBB) can be a predictor for development of significant
Externí odkaz:
https://doaj.org/article/1268a531f93b481ba8b28aee40ca407d
Autor:
Gillian L Gordon Perue, Esmeralda Segura, Domini Crandon, Francene A Gayle, Jude Charles, Nycole Josephs, Garly R Saint Croix, Mill Etienne, Herbert Mansosalva, Ryna Then, Violiza Inoa
Publikováno v:
Stroke. 54
Introduction: Alteplase is the only FDA approved thrombolytic agent for acute ischemic stroke, tenecteplase is rapidly emerging as an alternative. While both agents are readily available worldwide, low to middle income countries have limited access t
Autor:
Garly R. Saint Croix, Sunita Mahabir, Gabriel A. Hernandez, Angkawipa Trongtorsak, Michel Ibrahim, Sandra Chaparro, Veraprapas Kittipibul
Publikováno v:
Heart Failure Reviews. 27:533-543
Peripartum cardiomyopathy (PPCM) is a rare but potentially life-threatening form of heart failure (HF). Bromocriptine, a dopamine D2 agonist, has been used as an adjunctive treatment for PPCM with controversial benefits. A comprehensive literature se
Autor:
Michael Fattouh, Maria Irene Barillas-Lara, Spencer Lacy, Garly R. Saint Croix, Olivia Mechanic, Leili Behrooz, Michel Ibrahim
Publikováno v:
Heart Failure Reviews. 27:517-524
Transthyretin cardiac amyloidosis (ATTR-CM) is caused by the accumulation of misfolded transthyretin (TTR) protein in the myocardium. Diflunisal, an agent that stabilizes TTR, has been used as an off-label therapeutic for ATTR-CM. Given limited data
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventionsREFERENCES. 98(7)
OBJECTIVES This systematic review and meta-analysis compares direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) in patients with atrial fibrillation and bioprosthetic valve replacement or repair (BVR). BACKGROUND The optimal antic
Publikováno v:
Journal of Interventional Cardiology
Journal of Interventional Cardiology, Vol 2020 (2020)
Journal of Interventional Cardiology, Vol 2020 (2020)
Introduction. Transcatheter aortic valve replacement (TAVR) is now the treatment of choice for patients with severe aortic stenosis regardless of their surgical risk. Right bundle branch block (RBBB) can be a predictor for development of significant
Publikováno v:
International Journal of Heart Failure. 3:69
Renal dysfunction is a common comorbidity in patients with advanced heart failure who may benefit from left ventricular assist device (LVAD) therapy. The effect of preoperative renal dysfunction on clinical outcomes after LVAD implantation remains un
Autor:
Gabriel A. Hernandez, Michael Ibrahim, Garly R. Saint Croix, Sunita Mahabir, Veraprapas Kittipibul, Sandra Chaparro
Publikováno v:
Journal of Cardiac Failure. 26:S24
Background Peripartum cardiomyopathy (PPCM) is a rare but potentially life-threatening form of heart failure affecting women toward the end trimester of pregnancy, during delivery, or early postpartum period. Bromocriptine, a dopamine D2 agonist, has